Healthy Upside Potential: Cardiff Oncology Inc (CRDF)

With 0.61 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.65 million shares. The 52-week range on CRDF shows that it touched its highest point at $6.42 and its lowest point at $0.94 during that stretch. It currently has a 1-year price target of $10.50. Beta for the stock currently stands at 1.96.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRDF was down-trending over the past week, with a drop of -9.14%, but this was up by 84.54% over a month. Three-month performance surged to 262.84% while six-month performance rose 286.33%. The stock gained 225.45% in the past year, while it has gained 262.84% so far this year. A look at the trailing 12-month EPS for CRDF yields -0.93 with Next year EPS estimates of -1.05. For the next quarter, that number is -0.25. This implies an EPS growth rate of -4.78% for this year and -8.26% for next year.

Float and Shares Shorts:

At present, 44.68 million CRDF shares are outstanding with a float of 41.07 million shares on hand for trading. On Mar 15, 2024, short shares totaled 2.81 million, which was 6.30% higher than short shares on Feb 15, 2024. In addition to CRDF as the firm’s Cardiff Oncology, Inc., CRF serves as its Cornerstone Total Return Fund,.

Institutional Ownership:

Through their ownership of 15.17% of CRDF’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRDF since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, CRDF has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and CRDF currently yields $0.00. In the past year, CRDF’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, CRDF has a current buyback yield of $–. This was $– for the TTM, and it was $– for the past five years.